Charles N. Serhan

From WikiMD's WELLNESSPEDIA

Charles N. Serhan is an American biochemist and a pioneer in the field of lipid mediators and resolution physiology. He is currently the Simon Gelman Professor of Anaesthesia at Harvard Medical School and a Professor of Oral Medicine, Infection, and Immunity at Harvard School of Dental Medicine.

Early Life and Education[edit]

Charles N. Serhan was born in the United States. He completed his undergraduate studies in biochemistry at Stony Brook University, New York. He then pursued his Ph.D. in experimental pathology and medical sciences from New York University School of Medicine.

Career[edit]

After completing his Ph.D., Serhan joined the faculty of Harvard Medical School where he currently holds the Simon Gelman Professorship of Anaesthesia. He also serves as a Professor of Oral Medicine, Infection, and Immunity at Harvard School of Dental Medicine.

Research[edit]

Serhan's research primarily focuses on the molecular and cellular mechanisms of inflammation and its resolution. He is known for his pioneering work in the identification and structural elucidation of lipid mediators and their role in resolution physiology. His research has led to the discovery of a new genus of lipid mediators, termed resolvins, which are critical in controlling the resolution of acute inflammation.

Awards and Honors[edit]

Serhan's contributions to the field of lipid mediators and resolution physiology have earned him numerous awards and honors. These include the William Harvey Outstanding Scientist Medal, the American Society for Biochemistry and Molecular Biology (ASBMB) Merck Award, and the American Association of Immunologists (AAI) Excellence in Mentoring Award.

Publications[edit]

Serhan has authored and co-authored numerous scientific articles in peer-reviewed journals. His work has been published in prestigious journals such as Nature, Science, and The Journal of Experimental Medicine.

See Also[edit]

References[edit]


External Links[edit]

This article is a stub related to pharmacology. You can help WikiMD by expanding it!


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.